Search | TVST | ARVO Journals

Showing 1 – 20 of 46

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Development of audio-visual information material for patients with nAMD undergoing anti-VEGF therapy: education by explanatory videos in simple language shown during waiting times to reduce fear of treatment and non-adherence

Max Lange; Focke Ziemssen; Constantin Schreiber; Victoria Gazzotti-Sanchez; Louise Kühne; Jana Dulheuer; Lukas Maximilian Möhwald

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5998.

ARVO Imaging in the Eye Conference Abstract June 2023

Widefield OCTA vasculature visualization in SS-OCT

Lukas Rothmann; Homayoun Bagherinia; Warren Lewis; Zahra Nafar; Fritz Soecknick; Katharina Breher; Siegfried Wahl; Focke Ziemssen

Invest. Ophthalmol. Vis. Sci.. 2023; 64(9):PB0076.

ARVO Imaging in the Eye Conference Abstract June 2023

Single shot widefield swept-source OCTA imaging with 90 o add-on lens

Kique Romero; Thomas Callan; Zahra Nafar; Warren Lewis; Fritz Soecknick; Katharina Breher; Siegfried Wahl; Focke Ziemssen

Invest. Ophthalmol. Vis. Sci.. 2023; 64(9):PB0073.

ARVO Annual Meeting Abstract June 2023

Angiopoietin-1 and -2 are involved in PEDF-mediated neuroprotection in the retina

Focke Ziemssen; Jie Meng; Wolfram Eichler; Heidi Müller

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):5480.

ARVO Annual Meeting Abstract June 2023

Anti-VEGF preserves quality of life – results from the ALBATROS real-world data collection from Germany

Christian Wolfram; Norbert Pfeiffer; Tobias Hudde; Alexander Klatt; Birthe Schnegelsberg; Heven Midani-Oezkan; Focke Ziemssen; Alexander Schuster

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4225.

ARVO Annual Meeting Abstract June 2023

Ciliary muscle morphology during 13-month 0.01% Atropine treatment of childhood myopia: Results of the SAM IIT trial

Torsten Strasser; Sandra Wagner; Tobias Peters; Focke Ziemssen

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3404.

Artificial Intelligence April 2023

Multitask Learning for Activity Detection in Neovascular Age-Related Macular Degeneration

PDF

Murat Seçkin Ayhan; Hanna Faber; Laura Kühlewein; Werner Inhoffen; Gulnar Aliyeva; Focke Ziemssen; Philipp Berens
TAGS: exudative age-related macular degeneration, learning, maps
Trans. Vis. Sci. Tech.. 2023; 12(4):12. https://doi.org/10.1167/tvst.12.4.12

ARVO Annual Meeting Abstract June 2022

Effect of treatment and frequency of OCT monitoring on quality of life in neovascular age related macular degeneration (nAMD) and diabetic macular edema (DME). ALBATROS Data Collection

Norbert Pfeiffer; Christian Wolfram; Tobias Hudde; Alexander Klatt; Birthe Schnegelsberg; Heven Midani-Oezkam; Focke Ziemssen; Alexander Schuster

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):319 – F0150.

ARVO Annual Meeting Abstract June 2022

PEDF exerts neuroprotective effects on retinal ganglion cells via PEDF receptors

Jie Meng; Susanne Bürger; Annette Zwanzig; Mike Beck; Peter Wiedemann; Focke Ziemssen; Jan Darius Unterlauft; Eichler Wolfram

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):796 – F0355.

ARVO Annual Meeting Abstract June 2022

The expression of SARS-CoV 2 co-receptors and glia reaction in eyes of normal and COVID-19 diseased patients

Jose Hurst; Daniela Suesskind; Focke Ziemssen; Tarek Bayyoud; Sebastian Thaler; Sven Schnichels

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2373 – A0057.

ARVO Annual Meeting Abstract June 2022

Real-world outcomes of anti-VEGF therapy: psychological, social and behavioral factors measured by the ALBATROS data collection instrument BPZ-9.

Christian Wolfram; Norbert Pfeiffer; Tobias Hudde; Alexander Klatt; Birthe Schnegelsberg; Heven Midani-Oezkan; Focke Ziemssen; Alexander Karl-Georg Schuster

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):4224 – A0152.

ARVO Annual Meeting Abstract June 2021

The expression of SARS-CoV 2-receptors in ocular tissue of normal and COVID-19 diseased patients

Sven Schnichels; Daniela Süsskind; Jens Martin Rohrbach; Tarek Bayyoud; Focke Ziemssen; Sebastian Thaler; José Hurst

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1963.

ARVO Annual Meeting Abstract June 2021

Comparison of real-life treatment of naïve patients with ranibizumab over 24 months for neovascular AMD, diabetic macular edema, retinal vein occlusion and myopic CNV – results of the current interim analysis of the PACIFIC study

Ramin Khoramnia; Christos Haritoglou; Kristina Markova; Matthias Iwersen; Ulrike Michel; Salvatore Grisanti; Thomas Hammer; Jens Schrecker; Christoph Winkler von Mohrenfels; Focke Ziemssen

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):287.

ARVO Annual Meeting Abstract June 2020

Real world evidence of retinal vein occlusion (RVO) patient treatment with ranibizumab in Germany based on the 24 months interim results of the non-interventional, observational PACIFIC study

Katrin Lorenz; Christos Haritoglou; Kristina Markova; Berenice Rösler; Matthias Iwersen; Ulrike Michel; Bianca Apitzsch; Hüsnü Berk; Christian Karl Brinkmann; Ramin Khoramnia; Martin Scheffler; Jens Schrecker; Gregor Schwert; Focke Ziemssen

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1310.

ARVO Annual Meeting Abstract June 2020

Evaluation of nanorobots for targeted delivery into the retina

Sven Schnichels; Rahul Goyal; José Hurst; Focke Ziemssen; Tian Qiu; Peer Fischer

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1355.

ARVO Annual Meeting Abstract June 2020

Sitagliptin does not stabilize a VEGF-A-challenged barrier of retinal endothelial cells

Heidrun L Deissler; Anja Jaeckle; Juergen Kampmeier; Gabriele E Lang; Focke Ziemssen

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1753.

ARVO Annual Meeting Abstract July 2019

Interdisciplinary Communication: Ophthalmologists’ letters to secondary diabetes care centers

Lydia Marahrens; Daniel Roeck; Andreas Fritsche; Focke Ziemssen

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1091.

ARVO Annual Meeting Abstract July 2019

Presenting characteristics: The spectrum and prevalence of self-reported pain in ocular emergencies in a tertiary center of Southeast Africa

Friederike Charlotte Kortuem; Constanze Ilse Kortuem; Esther Misango; Petros Kayange; Justus Benrath; Focke Ziemssen

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2517.

ARVO Annual Meeting Abstract July 2019

Observation of ranibizumab treatment in real-life conditions – an interim analysis of the myopic choroidal neovascularization (mCNV) population within the observational, non-interventional PACIFIC study

Kristina Markova; Christos Haritoglou; Matthias Iwersen; Ulrike Michel; Martina Junge; Peter Geuking; Katrin Lorenz; Thomas Ach; Ramin Khoramnia; Andreas Schmidt; Judith Becker; Erik Beeke; Mathias Müller-Holz; Daniel Barthelmes; Focke Ziemssen

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4320.

ARVO Annual Meeting Abstract July 2019

Presence and progression of atrophic areas in pathological myopia

Charlotte Anne Melzer; Focke Ziemssen; Nicole Eter; Christian Karl Brinkmann; Hansjürgen Agostini; Gisela Haeusser-Fruh; Uwe Rose; Marc Schargus; Katrin Lorenz; Frank G Holz; Steffen Schmitz-Valckenberg

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4352.

1 2 3

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Development of audio-visual information material for patients with nAMD undergoing anti-VEGF therapy: education by explanatory videos in simple language shown during waiting times to reduce fear of treatment and non-adherence

Widefield OCTA vasculature visualization in SS-OCT

Single shot widefield swept-source OCTA imaging with 90 o add-on lens

Angiopoietin-1 and -2 are involved in PEDF-mediated neuroprotection in the retina

Anti-VEGF preserves quality of life – results from the ALBATROS real-world data collection from Germany

Ciliary muscle morphology during 13-month 0.01% Atropine treatment of childhood myopia: Results of the SAM IIT trial

Multitask Learning for Activity Detection in Neovascular Age-Related Macular Degeneration

Effect of treatment and frequency of OCT monitoring on quality of life in neovascular age related macular degeneration (nAMD) and diabetic macular edema (DME). ALBATROS Data Collection

PEDF exerts neuroprotective effects on retinal ganglion cells via PEDF receptors

The expression of SARS-CoV 2 co-receptors and glia reaction in eyes of normal and COVID-19 diseased patients

Real-world outcomes of anti-VEGF therapy: psychological, social and behavioral factors measured by the ALBATROS data collection instrument BPZ-9.

The expression of SARS-CoV 2-receptors in ocular tissue of normal and COVID-19 diseased patients

Comparison of real-life treatment of naïve patients with ranibizumab over 24 months for neovascular AMD, diabetic macular edema, retinal vein occlusion and myopic CNV – results of the current interim analysis of the PACIFIC study

Real world evidence of retinal vein occlusion (RVO) patient treatment with ranibizumab in Germany based on the 24 months interim results of the non-interventional, observational PACIFIC study

Evaluation of nanorobots for targeted delivery into the retina

Sitagliptin does not stabilize a VEGF-A-challenged barrier of retinal endothelial cells

Interdisciplinary Communication: Ophthalmologists’ letters to secondary diabetes care centers

Presenting characteristics: The spectrum and prevalence of self-reported pain in ocular emergencies in a tertiary center of Southeast Africa

Observation of ranibizumab treatment in real-life conditions – an interim analysis of the myopic choroidal neovascularization (mCNV) population within the observational, non-interventional PACIFIC study

Presence and progression of atrophic areas in pathological myopia

To View More...

You must be signed into an individual account to use this feature.